hair growth after glp 1 GLP-1 and Loss: Does Ozempic, Wegovy, or Tirzepatide Cause Hair Loss? Hairloss SOS : Regrowth Protocol

However, the most favorable effects on bone mineral density and microarchitecture were noted at concentrations much higher than those approved for human obesity treatment

Phase 2 data published in NEJM 2023 (Jastreboff et al.) documented up to 24.2% mean weight loss at 48 weeks vs 2.1% placebo in an obesity trial

Somatostatin analogues such as octreotide inhibit GLP-1 and insulin release

( Epub 20231129 )

Less commonly recognized but still valid qualifying conditions include prediabetes (elevated fasting glucose or A1C between 5.7-6.4%), polycystic ovary syndrome, non-alcoholic fatty liver disease, osteoarthritis of weight-bearing joints, and chronic kidney disease